Retroperitoneal leiomyosarcoma is a malignant mesenchymal tumor arising from smooth muscle cells and represents the second most common retroperitoneal sarcoma after liposarcoma. It typically presents between ages 50-70 with slight female predominance. Tumors are usually large at diagnosis (>10 cm) because the retroperitoneal space permits silent expansion. Histologically, they contain spindle cells with eosinophilic cytoplasm and cigar-shaped nuclei; desmin and SMA immunohistochemical markers are positive. On imaging, it appears as a large heterogeneously enhancing mass; necrosis and hemorrhage are common. IVC-origin leiomyosarcomas form a special subgroup. Surgical resection is the primary treatment but local recurrence rates are high (40-60%).
Age Range
40-70
Peak Age
55
Gender
Female predominant
Prevalence
Uncommon
Leiomyosarcoma originates from smooth muscle cells in the retroperitoneal space — from vessel walls (particularly IVC, gonadal veins, renal veins), ligaments, or embryonal smooth muscle remnants. Tumor cells show uncontrolled proliferation with RB1, TP53, and PTEN gene mutations playing roles in pathogenesis. Rapid growth leads to ischemic necrosis where tumor outgrows its blood supply — this necrosis appears as hypodense areas on CT and T2 hyperintense areas on MRI. The tumor's heterogeneous enhancement results from contrast between viable tumor tissue (dense neovascularization → early enhancement) and necrotic areas (no enhancement). Hemorrhage is common because neovascular vessels are fragile and disorganized — appearing as hyperintense foci on T1-weighted images. In IVC-origin leiomyosarcomas, the tumor shows intraluminal growth and can cause venous flow obstruction.
Intraluminal tumor extension seen as an enhancing solid mass within the IVC lumen is pathognomonic for IVC-origin leiomyosarcoma and the most important finding indicating the mass originates from the vessel wall.
On contrast-enhanced CT arterial phase, a large (usually >10 cm), irregularly marginated, heterogeneously enhancing retroperitoneal mass is seen. Viable tumor tissue shows intense enhancement while necrotic areas remain non-enhancing and hypodense. The mass typically displaces or invades surrounding structures (psoas muscle, kidney, IVC). Areas of active hemorrhage may show intense enhancement in the arterial phase.
Report Sentence
An approximately ___ cm, irregularly marginated, heterogeneously enhancing mass is seen in the retroperitoneal space with prominent necrotic areas; leiomyosarcoma should be primarily considered.
In the portal venous phase, IVC-origin or IVC-invading leiomyosarcomas show filling defect within the IVC lumen and/or IVC wall thickening. The tumor may show intraluminal growth and dilate the IVC. Extension into hepatic and renal veins should be evaluated. The cranial and caudal tumor margins at the IVC are critical for surgical planning.
Report Sentence
A filling defect with intraluminal extension is seen in the IVC lumen, consistent with IVC-origin leiomyosarcoma.
On T2-weighted MRI, leiomyosarcoma demonstrates markedly heterogeneous signal. Solid viable tumor tissue shows intermediate-to-high T2 signal, while necrotic/cystic areas show very high T2 signal (near-fluid). Hemorrhagic foci may appear hypointense on T2 (hemosiderin/deoxyhemoglobin). Fibrous bands show low T2 signal. This heterogeneous T2 pattern supports the diagnosis of an aggressive, necrotic sarcoma.
Report Sentence
The mass demonstrates markedly heterogeneous signal on T2-weighted images containing necrotic, hemorrhagic, and solid components; consistent with aggressive retroperitoneal sarcoma.
On T1-weighted images, leiomyosarcoma typically shows isointense to slightly hypointense signal relative to muscle. Hemorrhagic foci appear as hyperintense foci on T1 — reflecting the presence of methemoglobin. These T1 hyperintense hemorrhagic areas provide diagnostic clues as spontaneous hemorrhage is common in aggressive sarcomas. Necrotic areas appear hypointense on T1.
Report Sentence
Hyperintense foci are seen within the mass on T1-weighted images, consistent with subacute hemorrhage.
On DWI, the solid viable components of leiomyosarcoma show diffusion restriction (high DWI signal, low ADC value). Necrotic areas do not show diffusion restriction (low DWI, high ADC). This contrast is valuable in separating viable tumor tissue from necrotic regions and can be used for treatment response assessment. ADC values in viable tumor areas are typically in the range of 0.7-1.2 × 10⁻³ mm²/s.
Report Sentence
Diffusion restriction is seen in the solid components of the mass, consistent with high-cellularity viable tumor tissue.
On FDG PET-CT, leiomyosarcoma shows high FDG uptake (SUVmax typically >5-10). Uptake is heterogeneous — viable tumor areas show intense uptake while necrotic areas show low/no uptake. Higher-grade tumors demonstrate higher SUVmax values. PET-CT is also valuable for evaluating distant metastases (lung, liver, bone) and treatment response monitoring.
Report Sentence
Heterogeneously increased FDG uptake (SUVmax: ___) is seen in the retroperitoneal mass, consistent with high-grade sarcoma.
Criteria
Tumor originating from IVC wall showing intraluminal and/or extraluminal growth
Distinct Features
IVC dilatation, intraluminal filling defect, hepatic/renal vein extension; three segments: infrarenal (34%), renal-suprarenal (42%), suprahepatic (24%)
Criteria
Arising from retroperitoneal soft tissue (extravascular), large extraluminal mass
Distinct Features
No IVC involvement, displaces/invades surrounding structures, distinguished from liposarcoma by absence of fat
Criteria
Rare variant originating from gonadal vein (ovarian or testicular vein)
Distinct Features
More common in women (ovarian vein), may extend into IVC, presents as pelvic-retroperitoneal mass
Distinguishing Feature
UPS/MFH may be more homogeneous, distinguished by specific immunohistochemistry; leiomyosarcoma shows desmin/SMA positivity
Distinguishing Feature
Hemangiopericytoma shows more intense homogeneous enhancement with less prominent necrosis; necrosis is dominant in leiomyosarcoma
Distinguishing Feature
Lymphoma encases vessels without occlusion (sandwich sign), homogeneous mild enhancement; leiomyosarcoma shows vascular invasion and heterogeneous necrosis
Distinguishing Feature
SFT shows low T2 signal (collagen), intense homogeneous enhancement; leiomyosarcoma shows heterogeneous T2 signal and necrosis
Urgency
urgentManagement
surgicalBiopsy
NeededFollow-up
3-monthRetroperitoneal leiomyosarcoma is an aggressive sarcoma. Complete surgical resection (R0) forms the cornerstone of treatment. IVC-origin tumors may require IVC resection and reconstruction. Adjuvant radiotherapy and/or chemotherapy (doxorubicin-based) is controversial. Local recurrence rate is high (40-60%) requiring close surveillance. Metastasis most commonly spreads to lung, liver, and peritoneum.
Retroperitoneal leiomyosarcoma follows an aggressive course, and complete surgical resection is the most important prognostic factor. IVC-origin leiomyosarcomas require vascular surgery. Local recurrence is common (40-60%). Systemic chemotherapy provides limited benefit.